# Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder

> **NCT00514865** · PHASE2 · COMPLETED · sponsor: **Ono Pharma USA Inc** · enrollment: 278 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** ONO-2333Ms Experimental 2
- **DRUG:** Placebo
- **DRUG:** ONO-2333Ms Experimental 1

## Key facts

- **NCT ID:** NCT00514865
- **Lead sponsor:** Ono Pharma USA Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06-13
- **Primary completion:** 2008-04
- **Final completion:** 2008-06
- **Target enrollment:** 278 (ACTUAL)
- **Last updated:** 2023-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00514865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00514865, "Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00514865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*